URSA-PHARM-203: Patients with Opioid Use Last 12 Months
  • 27 Apr 2023
  • 1 Minute to read
  • Dark
    Light

URSA-PHARM-203: Patients with Opioid Use Last 12 Months

  • Dark
    Light

Article summary

Measure Description

Among patients with active plan membership and one or more outpatient medication fill in the last 12 months, the percentage with 2+ Opioid Fills and an aggregate days supply of 15 or great in the last 12 months. Excludes patients with any active CCW cancer condition or evidence of hospice at in the prior 12 months.

Metadata

  • Measure Type: Rate Measure
  • Temporal Structure: Entity
  • Component Class: Normal-Form
  • Denominator Case Field: Patient ID
  • Target Direction: Down

Denominator Description

Patients with active plan membership and one or more outpatient medication fill in the last 12 months; excludes patients with any active CCW cancer condition or evidence of hospice in the prior 12 months.

Numerator Description

Patients meeting denominator criteria and have 2+ Opioid Fills and an aggregate days supply of 15 or great in the last 12 months.

None.

FAQs

None.


Was this article helpful?